BONDI SANDS SPORT SPF 50 SUNSCREEN- avobenzone, homosalate, octisalate, octocrylene lotion 
Baxter Laboratories Pty. Ltd.

----------

Bondi Sands Sport SPF 50 Sunscreen Lotion

Active Ingredients

Avobenzone 3%, Homosalate 10%, Octisalate 5%, Octocrylene 8%

Purpose

Sunscreen

Uses

Warnings

For external use only

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

When using this product

keep out of eyes. Rinse with water to remove.

Other information

Inactive Ingredients

Water/Aqua/Eau, Beeswax/Cera Alba/Cire d'abeille, Aloe Barbadensis Leaf Juice, Isopropyl Palmitate, Cetearyl Alcohol, Cyclopentasiloxane, Cyclohexasiloxane, Ceteareth-20, Hydroxyacetophenone, Carbomer, Benzyl Alcohol, Saccharide Isomerate, Phenoxyethanol, Sodium Stearoyl Glutamate, Triethanolamine, Tocopheryl Acetate, Sodium Chloride, Citric Acid.

Questions?

888-266-0772 or visit bondisands.com

Product Packaging

bondi sands

The Australian tan

BROAD SPECTRUM

SPORT

SPF 50

SUNSCREEN LOTION

VERY WATER RESISTANT 80 MINUTES

SWEAT RESISTANT

COOL MOTION TECHNOLOGY

Australian Made

5.07 FL. OZ. (150mL)

sport spf50 lotion

BONDI SANDS SPORT SPF 50 SUNSCREEN 
avobenzone, homosalate, octisalate, octocrylene lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70157-015
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE30 mg  in 1 mL
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE80 mg  in 1 mL
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE100 mg  in 1 mL
OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE50 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
SODIUM STEAROYL GLUTAMATE (UNII: 65A9F4P024)  
SACCHARIDE ISOMERATE (UNII: W8K377W98I)  
BENZYL ALCOHOL (UNII: LKG8494WBH)  
CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)  
WATER (UNII: 059QF0KO0R)  
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
ISOPROPYL PALMITATE (UNII: 8CRQ2TH63M)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)  
CYCLOMETHICONE 6 (UNII: XHK3U310BA)  
POLYOXYL 20 CETOSTEARYL ETHER (UNII: YRC528SWUY)  
HYDROXYACETOPHENONE (UNII: G1L3HT4CMH)  
YELLOW WAX (UNII: 2ZA36H0S2V)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
TROLAMINE (UNII: 9O3K93S3TK)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70157-015-01150 mL in 1 TUBE; Type 0: Not a Combination Product05/23/2021
2NDC:70157-015-02400 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product08/02/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02005/23/2021
Labeler - Baxter Laboratories Pty. Ltd. (740537709)

Revised: 1/2024
Document Id: 0fb98c28-a44e-2cde-e063-6394a90a1aa8
Set id: 0fcc9d0d-a70f-0457-e063-6394a90ac154
Version: 1
Effective Time: 20240124
 
Baxter Laboratories Pty. Ltd.